PEDRO MERCADO: Open Payments
NPI 1366890055 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 10 payments from 9 companies in 2025. Trend: 2023 $254 · 2024 $733 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $245 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $117 |
| United Therapeutics Corporation | 1 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $109 |
| Viatris Specialty LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: ZEPBOUND, TEZSPIRE, Ohtuvayre, REXULTI, Ozempic, TYVASO, XIFAXAN, YUPELRI.
Industry payments across TX — which companies pay providers there.
